Showing results (1-10 of 333) with videos related to
Sort By:
Pageof 34
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Monoclonal antibodies raised against cultured cells and their application in cancer diagnosis]S Nozawa, Y UdagawaGan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1995
[What are the most appropriate operation procedures for endometrial cancer?]D Aoki, Y Udagawa, S NozawaGan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Clinical usefulness of tumor markers for the diagnosis of ovarian cancer]K Ito, Y Udagawa, S NozawaJournal of the National Cancer Institute|May 1, 1978
Effects of progesterone on human endometrial carcinoma cells in vivo and in vitroI Ishiwata, Y Udagawa, H Okumura, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1996
[Applications of tumor markers to the screening of endometrial and ovarian cancers]S Nozawa, K Takamatsu, K Tsukazaki, et al.International Journal of Oncology|November 18, 2000
Imbalanced expression of TAN-1 and human Notch4 in endometrial cancersT Suzuki, D Aoki, N Susumu, et al.Cancer Research|April 1, 1983
Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin beta-subunit, and pregnancy-specific beta 1-glycoprotein phenotypesS Nozawa, Y Udagawa, H Ohta, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1993
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level]S Nozawa, Y Udagawa, K Ito, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1993
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers]S Nozawa, Y Udagawa, K Ito, et al.Nihon Sanka Fujinka Gakkai Zasshi|February 1, 1984
[Biological properties of two newly established cell lines (SKG-3a,3b) from a human uterine cervical epidermoid carcinoma]Y Udagawa, S Nozawa, K Tsukazaki, et al.Pageof 34